发明申请
US20070275922A1 RNAi-MEDIATED INHIBITION OF IGF1R FOR TREATMENT OF OCULAR ANGIOGENESIS
审中-公开
IGF1R的RNAi介导的抑制作用以治疗血栓形成
- 专利标题： RNAi-MEDIATED INHIBITION OF IGF1R FOR TREATMENT OF OCULAR ANGIOGENESIS
- 专利标题（中）： IGF1R的RNAi介导的抑制作用以治疗血栓形成
-
申请号： US11617899申请日： 2006-12-29
-
公开(公告)号： US20070275922A1公开(公告)日： 2007-11-29
- 发明人: Jon Chatterton , David Bingaman
- 申请人： Jon Chatterton , David Bingaman
- 申请人地址： US TX Fort Worth
- 专利权人： Alcon Manufacturing, Ltd.
- 当前专利权人： Alcon Manufacturing, Ltd.
- 当前专利权人地址： US TX Fort Worth
- 主分类号： A61K31/7105
- IPC分类号： A61K31/7105 ; A61P7/00
摘要：
RNA interference is provided for inhibition of IGF1R mRNA expression for treating patients with ocular angiogenesis, particularly for treating retinal edema, diabetic retinopathy, sequela associated with retinal ischemia, posterior segment neovascularization (PSNV), and neovascular glaucoma, and for treating patients at risk of developing such conditions.
信息查询
IPC分类:
